Modafinil: A Review of Neurochemical Actions and Effects on Cognition
The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Abstract
Modafinil (2-[(Diphenylmethyl) sulfinyl] acetamide, Provigil) is an FDA-approved medication with wake-promoting properties. Pre-clinical studies of modafinil suggest a complex profile of neurochemical and behavioral effects, distinct from those of amphetamine. In addition, modafinil shows initial promise for a variety of off-label indications in psychiatry, including treatment-resistant depression, attention-deficit/hyperactivity disorder, and schizophrenia. Cognitive dysfunction may be a particularly important emerging treatment target for modafinil, across these and other neuropsychiatric disorders. We aimed to comprehensively review the empirical literature on neurochemical actions of modafinil, and effects on cognition in animal models, healthy adult humans, and clinical populations. We searched PubMed with the search term 'modafinil' and reviewed all English-language articles for neurochemical, neurophysiological, cognitive, or information-processing experimental measures. We additionally summarized the pharmacokinetic profile of modafinil and clinical efficacy in psychiatric patients. Modafinil exhibits robust effects on catecholamines, serotonin, glutamate, gamma amino-butyric acid, orexin, and histamine systems in the brain. Many of these effects may be secondary to catecholamine effects, with some selectivity for cortical over subcortical sites of action. In addition, modafinil (at well-tolerated doses) improves function in several cognitive domains, including workin…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, side effects of alpha agonists like guanfacine and clonidine include high prevalence of somnolence or sedating effects,168,169”
From Report of a Work Group on Sluggish Cognitive Tempo: Key Research Directions and a Consensus Change in Terminology to Cognitive Disengagement Syndrome (2023) · cites this paper as [168]
In the citing paper
“Modafinil, which is approved by the US Food and Drug Administration for the treatment of narcolepsy and its associated daytime sleepiness [59], is a logical candidate to address the hypoactive/sleepy aspects of CDS.”
Citations
Cites
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472 · cited 7×
“Importantly, modafinil also augments pupillary dilation parameters (Hou et al, 2005) in a manner consistent with LC phasic responses to task-relevant events (Beatty, 1982a, b; Richer and Beatty, 1987), suggesting the potential for LC/NE system effects in optimizing cognitive task performance, as described in the Aston…”
BackgroundMethodResultInfluentialNarcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 3×
“m Fos in orexin neurons in perfornical area 150 mg/kg i.p. Immunohisto-chemistry Mice Chemelli et al, 1999 75 mg/kg i.p. Immunohisto-chemistry Rat Scammell et al, 2000 No binding to orexin-1 receptor IC50 410mM 125I-human-orexin B displacement Transfected Chinese Hamster Ovary cells Wieland et al,…”
BackgroundAston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960 · cited 1×
“It appears also that when levels of tonic LC activity are minimal, such as during sleep, grooming, and eating, that phasic responses are also less robust (Aston-Jones and Bloom, 1981).”
BackgroundTask-evoked pupillary responses, processing load, and the structure of processing resources.
Beatty, J. (1982) · Psychological Bulletin · doi:10.1037/0033-2909.91.2.276 · Cited by 1,959 · cited 1×
“…modafinil also augments pupillary dilation parameters (Hou et al, 2005) in a manner consistent with LC phasic responses to task-relevant events (Beatty, 1982a, b; Richer and Beatty, 1987), suggesting the potential for LC/NE system effects in optimizing cognitive task performance, as described…”
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
Seamans, J. K., & Yang, C. R. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.006 · Cited by 1,592 · cited 15×
“Inhibition of DA cell firing in VTA/SN; blocked by Sulpiride 10mM but not by Prazosin 20 mM Extracellular recording Rat brain slice Korotkova et al, 2006 Hyperpolarization of VTA neurons, blocked by Sulpiride 10mM 20–50mM Whole-cell patch clamp Isolated VTA neurons No effect on mesencephalic DA neuron activity 128 mg/…”
BackgroundInfluentialDissociation in prefrontal cortex of affective and attentional shifts
Dias, R., Robbins, T. W., & Roberts, A. C. (1996) · Nature · doi:10.1038/380069a0 · Cited by 1,527
D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory
Sawaguchi, T., & Goldman-Rakic, P. S. (1991) · Science · doi:10.1126/science.1825731 · Cited by 1,364
The role of histamine and the tuberomamillary nucleus in the nervous system
Haas, H., & Panula, P. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1034 · Cited by 929 · cited 5×
“Thalamic NET occupancy: 16, 44% 5, 8 mg/kg i.v. PET with [11C]MeNER Rhesus monkey Madras et al, 2006 NET binding IC50¼ 35.6mM [3H] NE Human Embryo Kidney No effect on pontine NE neuron activity 128 mg/kg i.p. Single-unit recording Rat (anesthetized) Akaoka et al, 1991 Extracellular NE: m in PFC, medial hypothalamus 12…”
BackgroundInfluentialDopaminergic Role in Stimulant-Induced Wakefulness
Wisor, J. P., Nishino, S., Sora, I., Uhl, G. H., Mignot, E., & Edgar, D. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01787.2001 · Cited by 769 · cited 7×
“…extracellular DA levels (measured by microdialysis) that are increased significantly in the rat prefrontal cortex (PFC) (de Saint Hilaire et al, 2001), and in the caudate nucleus of narcoleptic dogs (Wisor et al, 2001), although only minimally in the rat hypothalamus (de Saint Hilaire et al, 2001).”
BackgroundInfluentialThe role of locus coeruleus in the regulation of cognitive performance
Usher, M., Cohen, J. D., Servan-Schreiber, D., Rajkowski, J., & Aston-Jones, G. (1999) · Science · doi:10.1126/science.283.5401.549 · Cited by 715
Research works printed but not linked: 1
- Wong YN, Simcoe D, Hartman LN, Laughton WB, King SP, McCormick GC et al (1999b). A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clin Pharmacol 39: 30–40. · DOI · Paper page
Cited by
Items 601–700 of 735
Kathiriya, P. (2014) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v4i3.845 · Cited by 1
Non-Narcoleptic Hypersomnias of Central Origin
Billiard, M. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1703-7.10023-4 · Cited by 1
Proper administration of psychostimulants
Nam, B. (2018) · Journal of Korean Medical Association · doi:10.5124/jkma.2018.61.8.502 · Cited by 1
“분명한 기전이 밝혀지지는 않 았지만, 도파민, 노르에피네프린 단독 혹은 양쪽에 모두 작 용하는 것으로 보이며 다른 신경전달 물질 시스템에는 이 차적인 작용을 하는 것으로 보인다[27].”
Psychopharmaka zum pharmakologischen Neuroenhancement und ihr Missbrauchspotenzial
Franke, A. G. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23021-9.00025-4 · Cited by 2
Promises and Perils of Neuroenhancement and its Perspectives for Military Ethics
Orzechowski, M., & Steger, F. (2018) · Acta Universitatis Lodziensis Folia Philosophica Ethica-Aesthetica-Practica · doi:10.18778/0208-6107.32.02 · Cited by 1
Assessment and Management of Psychiatric Symptoms Among Adults With Mild Traumatic Brain Injury
Brenner, L. A., Otis, J., Grassmeyer, R. P., Adams, R. S., Laker, S. R., & Filley, C. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-65384-8.00005-5 · Cited by 1
Franke, A. G. (2020) · Springer eBooks · doi:10.1007/978-3-658-28263-9_4 · Cited by 1
Efectos adversos a nivel cardiovascular y neurológico asociados al consumo de modafinilo
Lozano, D. F. S., Londoño, N. H. R., González, D. J. L., Barbosa, A. M., & Restrepo, O. J. M. (2020) · Revista Médicas UIS · doi:10.18273/revmed.v33n1-2020004 · Cited by 1
Hama, T., Koeda, M., Ikeda, Y., Tateno, A., Kawara, T., Suzuki, H., & Okubo, Y. (2021) · Journal of Nippon Medical School · doi:10.1272/jnms.jnms.2021_88-607 · Cited by 1
“There were no significant drug effects on the three mood factors of Alertness, Contentedness and Calmness.”
InfluentialKooij, J. J. S. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4138-9_4 · Cited by 1
von Heyden, M. (2017) · Springer eBooks · doi:10.1007/978-3-642-55125-3_54 · Cited by 2
Vadagandla, K., Reddy, P. S., Antony, S., & Reddy, P. P. (2022) · Cureus · doi:10.7759/cureus.23354 · Cited by 3
“In addition to promoting wakefulness, modafinil is known to be beneficial in improving cognitive function which was reviewed by Minzenberg and Carter in their literature [20].”
BackgroundNeurologic complications in the treatment of childhood malignancies
Liou, A., Kline, C., & Mueller, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821976-8.00005-0 · Cited by 1
Gründer, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_61 · Cited by 4
Özsoy, Ş. (2023) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2023.100684 · Cited by 1
Celaya, C. A., Araiza, D. G., & Reina, M. (2022) · Mundo Nano Revista Interdisciplinaria en Nanociencia y Nanotecnología · doi:10.22201/ceiich.24485691e.2022.29.69731 · Cited by 1
“…contra el VIH, el cáncer, la hepatitis y el tratamiento de tras-tornos neurodegenerativos (Gu, Zhang y Lamon, 2016; Mias, Sudor y Camon, 2008; Minzenberg y Carter, 2008; Santosh et al ., 2012; Bakry et al ., 2007; Sal-vador-Morales et al ., 2008; Chigo-Anota et al ., 2015; Schuster, Wilson y…”
The neuroreceptors and transporters underlying spontaneous brain activity
Nakuci, J., & Bansal, K. (2025) · Communications Biology · doi:10.1038/s42003-025-08492-z · Cited by 1
Drosophila Models in Therapeutic Drug Discovery Related to Aging
Nichols, C. D. (2015) · Healthy ageing and longevity · doi:10.1007/978-3-319-18326-8_9 · Cited by 1
Psychopharmakologische Interventionen für Neuroenhancement bei gesunden Menschen
Repantis, D. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-9505 · Cited by 1
TDAH en adultos factores genéticos, evaluación y tratamiento farmacológico
Ramos‐Quiroga, J. A. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 9
Scoriels, L., Barnett, J. H., Murray, G. K., Sahakian, B. J., Cherukuru, S., Fielding, M., Cheng, F., & Jones, P. B. (2009) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(09)70087-2 · Cited by 1
Adjunctive Therapy for Long-Term Support of Cognitive Impairment
Dearborn, J. T., Maloney, S. E., Hicklin, N., Lane, E., & Paul, R. H. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-434-6_12 · Cited by 1
Angelis, O. D. (2016) · UTAS Research Repository · doi:10.25959/23239091 · Cited by 1
Hama, T. (2021) · Institutional Repositories DataBase (IRDB) · Cited by 1
Short-Term and Working Memory in Humans
Cools, R. (2014) · Springer eBooks · doi:10.1007/978-3-642-27772-6_183-3 · Cited by 1
Sarter, M. F. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_337 · Cited by 1
López‐Amador, N. (2025) · Qeios · doi:10.32388/zozbh7 · Cited by 1
The acute effects of modafinil on behavioural and ERP measures of attention
Harris, C. (2016) · UTAS Research Repository · doi:10.25959/23239211 · Cited by 1
Evaluation of Modafinil in Preclinical Behavioral Assays of Abuse Liability
Quisenberry, A. J. (2013) · ScholarWorks - WMU (Western Michigan University)
Assessment and treatment of cognitive impairment and related features
Harvey, P. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.014
Quisenberry, A. J., Watkins, E. E., Harvey, E. L., & Walters, J. L. (2013)
Over the Counter Purchase and Off-Label Use of Modafinil
Sayar, G. H., & Çetin, M. (2015) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20150720010822
Boosting impulse control in addiction. Pharmacological neuroimaging studies
Schmaal, L. (2013) · UvA-DARE (University of Amsterdam)
Gather, J. (2011) · Medicine Studies · doi:10.1007/s12376-011-0060-x
Uso de modafinilo en astenia por cáncer avanzado
Portela, M. A., Centeno, C., & Rubiales, Á. S. (2011) · Medicina Paliativa · doi:10.1016/j.medipa.2011.10.004
Brave new interactions: performance-enhancing drugs for human-computer interaction
Pohl, H. (2014) · CHI Conference Extended Abstracts on Human Factors in Computing Systems (CHI EA) · doi:10.1145/2559206.2578882
“, in shift-work or emergency situations can be aided by drugs such as modafinil (Provigil) [18, 25].”
BackgroundGin and Juice: Modafinil Tightens Up the Drinker's Brain at Rest
Minzenberg, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.018
Self-citationReply to Augmentation of Dopaminergic Agents for Major Depressive Disorder
Ravindran, A. V., Kennedy, S. H., & Binder, C. E. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08lr04686a
Augmentation of Dopaminergic Agents for Major Depressive Disorder
Pae, C., Patkar, A. A., & Masand, P. S. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08lr04686
Modafinil, Inhibitory Control, and Alcoholism
Chamberlain, S. R. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.011
Neurocognitive Impairment (NI)
Kumar, N. B. (2012) · Springer eBooks · doi:10.1007/978-3-642-27233-2_9
Writers, A. M. (2014) · Drugs & Therapy Perspectives · doi:10.1007/s40267-014-0114-8
Innovative Therapeutics for Schizophrenia
Breier, A. F., & Shekhar, A. (2009) · Psychopharm Review · doi:10.1097/01.idt.0000345193.21201.89
“It has effects on multiple neurotransmitter systems including dopamine, norepinephrine, serotonin, GABA, and glutamate.(28) Some studies report that modafinil improves cognitive performance in healthy, non-sleep-deprived subjects, including improvement in digit span, visual recognition, spatial planning, sustained att…”
BackgroundResultInfluentialPharmakologisches Neuroenhancement: Substanzen und Epidemiologie
Lieb, K., & Franke, A. G. (2012) · Psychiatrie und Psychotherapie up2date · doi:10.1055/s-0032-1305091 · Cited by 3
Compounds that alter sleep and wakefulness
Murray, S. L., & Thimgan, M. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802412-6.00015-7 · Cited by 1
Chau, S. A. (2013) · TSpace (University of Toronto)
Do the stimulant medications improve neuropsychological performance of college students with ADHD?
Luo, C. (2009) · Louisiana State University · doi:10.31390/gradschool_theses.3405
“5 Bupropion is a non-selective inhibitor of dopamine transporter (DAT) and norepinephrine transporter (NET) and is also an antagonist at neural nicotinic acetylcholine receptors (Dwoskin, Rauhut, KingPospisil, & Bardo, 2006).”
BackgroundModafinil as a cognitive enhancer
Yannix, J. (2017) · Vassar Scholarship (Vassar College)
Nuijten, M. (2017) · Leiden Repository (Leiden University) · Cited by 1
Boot, N. C. (2018) · UvA-DARE (University of Amsterdam) · Cited by 2
Loued‐Khenissi, L. (2018) · Infoscience (Ecole Polytechnique Fédérale de Lausanne) · doi:10.5075/epfl-thesis-8432
Sadness/Demoralisation and Apathy
Picardi, A., Gaetano, P., & Fabi, E. (2018) · Springer eBooks · doi:10.1007/978-3-319-78202-7_6
Giuseppin, A. F. (2012) · Utrecht University Repository (Utrecht University)
Treating Narcolepsy and Idiopathic Hypersomnia
Masri, T. J., Jain, V., & Guilleminault, C. (2018) · Springer eBooks · doi:10.1007/978-1-4939-8607-1_10
Etude multimodale in vivo des mécanismes de toxicité neurorespiratoire des opioïdes chez le rat
Vodovar, D. (2018) · theses.fr (ABES) · doi:10.70675/633f744bzee7fz46c3z913ezf6340f8c5c1e
Learning to focus and focusing to learn : more than a cortical trick
Dhawan, S. S. (2018) · St Andrews Research Repository (St Andrews Research Repository)
Júnior, A. T. T. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2019.tde-20032019-161250
Franke, A. G. (2019) · Springer eBooks · doi:10.1007/978-3-662-58853-6_8
The effect of Modafinil on behavioural and ERP measures of attention and associated sex differences
Shaw, H. (2018) · UTAS Research Repository · doi:10.25959/23238080
Ethical Issues in Neuropsychopharmacotherapy: US Perspective
Menconi, M. J., & Dubljević, V. (2020) · Springer eBooks · doi:10.1007/978-3-319-56015-1_380-1
Kinslow, C. J., & Miller, E. C. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.01.002
Saakian, A. G., Ts, K., Norinskiĭ, E. M., & Bv, K. (1983) · PubMed · Cited by 1
Sarter, M. F. (2014) · Springer eBooks · doi:10.1007/978-3-642-27772-6_337-2
Sarter, M. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_337
Medications Affecting Behavior and Learning
Goldstein, S., Naglieri, J. A., & DeVries, M. L. (2011) · Wiley eBooks · doi:10.1002/9781118093085.ch18
(2010) · Wiley eBooks · doi:10.1002/9781444328172.refs
Nichols, D. E. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc243
von Heyden, M. (2017) · Springer eBooks · doi:10.1007/978-3-642-55214-4_54-1
Psychostimulants as cognitive enhancers – the evidence for the use and abuse of smart drugs
Goldsmith, P., Anderson, K. N., & Royal Victoria Infirmary, N. U. T. (2022) · Advances in Clinical Neuroscience & Rehabilitation · doi:10.47795/cuun2886
Anghelescu, I., & Ahlers, E. (2021) · Springer eBooks · doi:10.1007/978-3-030-21573-6_128-1
Nader, M. A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727378029.793553498
Minzenberg, M. (2014) · Springer eBooks · doi:10.1007/978-3-642-27772-6_370-2
Self-citationPeer Review #3 of "Modafinil decreases anxiety-like behaviour in zebrafish (v0.1)"
(2017) · PeerJ · doi:10.7287/peerj.2994v0.1/reviews/3
“235 Modafinil has been shown to occupy bindings sites on the dopamine transporter (DAT) 236 and norepinephrine transporter (NAT) with modest affinity compared to other psychostimulants 237 like methylphenidate (Ritalin; Madras et al., 2006; Minzenberg and Carter, 2008).”
Brell, J. M., & Jones, L. W. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00045-x · Cited by 1
Morgan, M. M. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_370
Short-Term and Working Memory in Humans
Cools, R. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_183
Short-Term and Working Memory in Humans
Cools, R. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_183
Minzenberg, M. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_370
Self-citationOyesanya, M., & Al‐Juffali, N. (2022) · BJPsych Advances · doi:10.1192/bja.2022.36
New Strategies to Improve Cognitive Symptom Domain in the Treatment of Schizophrenia
Barlati, S., Ariu, C., Garozzo, A., & Vita, A. (2022) · Springer eBooks · doi:10.1007/978-3-031-09058-5_2 · Cited by 1
Chávez, J. F. I., Angeles, M. M. M., Carrasco, R. T., Jiménez, A. R., & Vazquez, M. M. P. (2023) · doi:10.61482/biyu.23.01
Xu, P., Zhao, X., Wang, B., & Wang, H. (2023) · Research Square · doi:10.21203/rs.3.rs-3699940/v1
Cerebellar-cortical connectivity in bipolar disorder: Exploring the regulatory action of modafinil
Cunha, M. G. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111230
Studies of the effects of aqueous extract of Garcinia kola on fatigue and memory in Wistar Rats
Kangah, A. N. A. D. K., Gbalou, K. L., Silué, S., Bou, R., N’guessan, N. A., & Glin, L. (2023) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/23.2.264-276
Clinical and Pharmacological Characteristics of the Drug Modafinil
Кевра, М. К., Gavrilenko, L. N., & Popov, A. S. (2023) · Рецепт · doi:10.34883/pi.2023.26.6.017
Modafinil Use in an Adolescent With Major Depressive Disorder
Çakır, E. Ö., Karakuş, O. B., & Adak, İ. (2024) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001893
Awareness and use of the “cognitive enhancer” prescription drug modafinil in medical studentsPreprint
Novoselova, T. V., Myatt, N., Murray, E., Malekigorji, M., & Robson, L. G. (2024) · medRxiv · doi:10.1101/2024.08.08.24311625
Zack, M. H., Behzadi, A., Biback, C., Chugani, B., DiGiacomo, D., Fang, T., Houle, S., Kalia, A., Lobo, D. S. S., Payer, D. E., et al. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173865
Psychopharmaka zum pharmakologischen Neuroenhancement und ihr Missbrauchspotenzial
Franke, A. G. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21074-7.00038-1
Metadata
- Authors
- Minzenberg, M. J., & Carter, C. S.
- Affiliations
- University of California Davis Medical Center (US)
- Corresponding author
- Minzenberg, Michael J
- Venue
- Neuropsychopharmacology
- Published
- 2007-08-22
- Volume
- 33
- Issue
- 7
- Pages
- 1477-1502
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2122011624
- Semantic Scholar
- cf5b2a15296e7832bcfdd965f28583772ef2999c
- Cited by
- 713
- References
- 215
- Citations by year
- 2026: 18 · 2025: 32 · 2024: 25 · 2023: 33 · 2022: 33 · 2021: 46 · 2020: 26 · 2019: 19 · 2018: 33 · 2017: 42 · 2016: 22 · 2015: 49 · 2014: 48 · 2013: 62 · 2012: 59
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH 59883, MH066629, R01MH059883, R01MH066629)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Keywords
- modafinil, wakefulness-promoting agents, neurochemical mechanisms, cognition, catecholamines, serotonin, glutamate, GABA, orexin, histamine, working memory, episodic memory, prefrontal cortex, cognitive control, treatment-resistant depression, attention deficit hyperactivity disorder, schizophrenia, cognitive impairment, pharmacokinetics, abuse liability
- MeSH terms
- Modafinil, Animals, Mental Disorders, Benzhydryl Compounds, Brain Chemistry, Cognition, Humans, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.